The synchronized feature of Saururus chinensis and gut microbiota against T2DM, NAFLD, obesity and hypertension via integrated pharmacology
Source abstract
Abstract
Type 2 diabetes mellitus (T2DM), nonalcoholic fatty liver disease (NAFLD), obesity (OB) and hypertension (HT) are categorized as metabolic disorders (MDs), which develop independently without distinct borders. Herein, we examined the gut microbiota (GM) and Saururus chinensis (SC) to confirm their therapeutic effects via integrated pharmacology. The overlapping targets from the four diseases were determined to be key protein coding genes. The protein–protein interaction (PPI) networks, and the SC, GM, signalling pathway, target and metabolite (SGSTM) networks were analysed via RPackage. Additionally, molecular docking tests (MDTs) and density functional theory (DFT) analysis were conducted to determine the affinity and stability of the conformer(s). TNF was the main target in the PPI analysis, and equol derived from Lactobacillus paracasei JS1 was the most effective agent for the formation of the TNF complex. The SC agonism (PPAR signalling pathway), and antagonism (neurotrophin signalling pathway) by SC were identified as agonistic bioactives (aromadendrane, stigmasta-5,22-dien-3-ol, 3,6,6-trimethyl-3,4,5,7,8,9-hexahydro-1H-2-benzoxepine, 4α-5α-epoxycholestane and kinic acid), and antagonistic bioactives (STK734327 and piclamilast), respectively, via MDT. Finally, STK734327-MAPK1 was the most favourable conformer according to DFT. Overall, the seven bioactives from SC and equol that can be produced by Lactobacillus paracasei JS1 can exert synergistic effects on these four diseases.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Gut microbiota and health · Computational Drug Discovery Methods · Tryptophan and brain disorders
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Institute for Liver and Digestive Diseases, College of Medicine, Hallym University, Chuncheon, South Korea
Funding
Hallym University Research Fund · the Basic Science Research Program through the National Research Foundation of Korea · Ministry of Education, Science and Technology · Korea Institute for Advancement of Technology · Bio Industrial Technology Development Program · Ministry of Trade, Industry and Energy
References (50)
Show source-provided references
1. 10.4103/IJEM.IJEM_585_1710.4103/IJEM.IJEM_585_17 ↗
2. 10.1186/S12889-022-12509-1/TABLES/210.1186/S12889-022-12509-1/TABLES/2 ↗
3. 10.3389/FCVM.2022.94275310.3389/FCVM.2022.942753 ↗
4. 10.3892/ETM.2016.366710.3892/ETM.2016.3667 ↗
5. 10.3390/IJMS2310575710.3390/IJMS23105757 ↗
6. 10.1186/s12906-019-2671-910.1186/s12906-019-2671-9 ↗
7. 10.1096/FJ.202002126RR10.1096/FJ.202002126RR ↗
8. 10.1016/J.JEP.2008.04.01110.1016/J.JEP.2008.04.011 ↗
9. 10.7717/PEERJ.10043/SUPP-210.7717/PEERJ.10043/SUPP-2 ↗
10. 10.3390/NU1516353410.3390/NU15163534 ↗
11. 10.3390/IJMS2215807410.3390/IJMS22158074 ↗
12. 10.3390/CELLS11182903/S110.3390/CELLS11182903/S1 ↗
13. 10.1080/21691401.2023.220373410.1080/21691401.2023.2203734 ↗
14. 10.1002/CTM2.139210.1002/CTM2.1392 ↗
15. 10.1080/21691401.2022.215566110.1080/21691401.2022.2155661 ↗
16. 10.3389/FENDO.2020.0002510.3389/FENDO.2020.00025 ↗
17. 10.4014/JMB.1404.0406010.4014/JMB.1404.04060 ↗
18. 10.1016/S0014-5793(97)00467-510.1016/S0014-5793(97)00467-5 ↗
19. 10.1002/JSFA.964810.1002/JSFA.9648 ↗
20. 10.3945/JN.109.11978410.3945/JN.109.119784 ↗
21. 10.3390/IJMS22241347510.3390/IJMS222413475 ↗
22. 10.1186/s12967-023-04122-610.1186/s12967-023-04122-6 ↗
23. 10.3389/FPHAR.2021.74692310.3389/FPHAR.2021.746923 ↗
24. 10.1021/acs.jmedchem.7b0023710.1021/acs.jmedchem.7b00237 ↗
25. 10.1038/NBT128410.1038/NBT1284 ↗
26. 10.1093/NAR/GKZ38210.1093/NAR/GKZ382 ↗
27. 10.1371/JOURNAL.PONE.017055110.1371/JOURNAL.PONE.0170551 ↗
28. 10.1016/J.CSBJ.2021.05.01510.1016/J.CSBJ.2021.05.015 ↗
29. 10.1093/NAR/GKI03310.1093/NAR/GKI033 ↗
30. 10.1016/J.BIOPHA.2019.10937010.1016/J.BIOPHA.2019.109370 ↗
31. 10.1186/S12906-020-02909-4/FIGURES/710.1186/S12906-020-02909-4/FIGURES/7 ↗
32. 10.1093/NAR/GKAA107410.1093/NAR/GKAA1074 ↗
33. 10.2147/AABC.S6374910.2147/AABC.S63749 ↗
34. 10.1016/j.molstruc.2020.12776210.1016/j.molstruc.2020.127762 ↗
35. 10.1016/B0-08-045044-X/00085-710.1016/B0-08-045044-X/00085-7 ↗
36. 10.1155/2020/187841010.1155/2020/1878410 ↗
37. 10.1038/s42255-021-00470-z10.1038/s42255-021-00470-z ↗
38. 10.3390/NU1109223110.3390/NU11092231 ↗
39. 10.1016/J.BCP.2005.10.00910.1016/J.BCP.2005.10.009 ↗
40. 10.1016/J.BBRC.2015.02.15410.1016/J.BBRC.2015.02.154 ↗
41. 10.1073/PNAS.071173410510.1073/PNAS.0711734105 ↗
42. 10.1371/JOURNAL.PONE.012537110.1371/JOURNAL.PONE.0125371 ↗
43. 10.1371/JOURNAL.PONE.005286910.1371/JOURNAL.PONE.0052869 ↗
44. 10.3920/BM2011.005210.3920/BM2011.0052 ↗
45. 10.1038/NM.410210.1038/NM.4102 ↗
46. 10.1089/ADT.2019.94310.1089/ADT.2019.943 ↗
47. 10.2174/13816120778279427510.2174/138161207782794275 ↗
48. 10.3390/MOLECULES2310247910.3390/MOLECULES23102479 ↗
49. 10.1073/PNAS.83.22.844010.1073/PNAS.83.22.8440 ↗
50. 10.1021/acs.biochem.5b0137810.1021/acs.biochem.5b01378 ↗